Researchers from Brigham and Women’s Hospital in Boston used digital pill systems to track pills ingestion through signals emitted by the capsules. They studied 15 HIV-negative men who have sex with men and had a history of substance use.
The study was conducted because even though PrEP has been shown to be 99 percent effective at preventing HIV when taken correctly, many patients struggle to adhere to the drug’s once-daily regimen.
Trial participants said the system was easy to learn and incorporate in their daily routine. They also said they found the system’s smartphone app helpful, as it allowed them to confirm whether they had taken their pill.
“While this technology will likely not be used in cheaper medications or those with less impact, it could improve outcomes for expensive or lifesaving medications, like those for congestive heart failure, hepatitis C, or diabetes,” Peter Chai, MD, one of the study’s authors, said in a Dec. 7 news release. “In this era of digital health, technologies like digital pill systems are connecting doctors to patients a little better.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
